Jake Bauer - Apr 18, 2025 Form 3 Insider Report for Immunovant, Inc. (IMVT)

Role
Director
Signature
/s/ Christopher Van Tuyl, Attorney-in-Fact
Stock symbol
IMVT
Transactions as of
Apr 18, 2025
Transactions value $
$0
Form type
3
Date filed
4/28/2025, 05:02 PM
Previous filing
Feb 10, 2025
Next filing
May 5, 2025

No securities are beneficially owned.